Clin2
NCT06756490Worth exploringRecruiting

Study of HY-2003 for double chin reduction

Moderate or Severe Submental Fullness

Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.

This study tests a new medicine called HY-2003 to reduce extra fat under the chin (double chin). It is for adults who have moderate to severe submental fat and want to see if injections can help.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have moderate to severe double chin as assessed by a doctor.
  • You are between 18 and 65 years old.
  • Your weight has been stable for at least 6 months.
  • You have not had any surgery, liposuction, or injections in the chin or neck area before.
  • You are not allergic to deoxycholic acid or anesthetics like lidocaine.
  • You are willing to use effective birth control during and for 6 months after the study (if applicable).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07749742Recruiting· Phase 1
Study of MI226 injection for belly fat

This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.

Beijing, Beijing Municipality
NCT07421297Recruiting· Phase 3
Study of SYH2053 for high cholesterol in Chinese adults

This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.

Beijing, Beijing Municipality
NCT07421284Not yet recruiting· Phase 3
New cholesterol-lowering medication for high cholesterol

This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.

Beijing, Beijing Municipality
NCT07677683Recruiting· Phase 2
STP705 injection for chin fat reduction

This study tests an injection called STP705 to reduce fat under the chin. It may be a good option if you have moderate to severe chin fat and want a non-surgical treatment.

Sydney, New South Wales
NCT07864246Not yet recruiting
Evaluating treatments for double chin at Assiut University

This study looks at how to assess and manage submental fat, also known as a double chin. If you have a double chin and are interested in cosmetic improvement, this trial may be an option for you.

NCT07140939Recruiting· Phase 3
Reducing belly fat with an injection: CBL-514 trial

This trial tests a new injection called CBL-514 that is designed to reduce fat under the skin in the belly area. It might help people who are dissatisfied with stubborn abdominal fat that doesn't go away with diet and exercise.

Encinitas, California

Hear when a new Moderate or Severe Submental Fullness trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.